- Global Pharma News & Resources

Glycated Albumin Market to Surpass US$ XX Mn Threshold by 2027 at a XX% CAGR | Generated Opportunities for Growth in The Global Glycated Albumin Industry

The Glycated Albumin Market analysis report speaks about the growth rate till 2027 manufacturing process, Growth, key factors driving this market with sales, revenue, and price analysis of lead manufacturers, distributors, traders and dealers of Glycated Albumin.

Coherent Market Insights always aims at offering their clients an in-depth analysis and the best research of the various market. The “Glycated Albumin Market projected to develop with growing expansion prospects”. The Glycated Albumin Market report presents a calculated opinion of the analyzed Glycated Albumin Market data. It explains various opportunities dedicated to different industries, suppliers, organizations, and associations offering various products and services such as offering them precise guidance for their expansion in the competition for reliable services to consumers.

Request Here Sample Report

Glycation is the process of a sugar molecule joining together. For example, glucose to albumin, a protein or lipid molecule. Glycated albumin is albumin with glucose attached to it. Albumin is a protein molecule found in the blood, main body organs, and bodily fluids. Albumin’s job is to keep the cell in form and transfer hormones and nutrients..

When blood glucose levels are low, the amount of albumin in the body falls, and when blood glucose levels are high, the amount of albumin in the body increases. Glycated albumin is assessed to establish the medication dose for diabetes therapy during the commencement of diabetic medications. Glycated albumin was reported as a novel biomarker for the identification and management of diabetes in a study done by the American Association for Clinical Study in 2011. Glycemic management is required for diabetes treatment. Glycated haemoglobin (HbA1c), 1, 5-anhydroglucitol (1,5AG), and glycated albumin are some of the measures utilised to provide markers. The glycemic level during the first three months of diabetes incidence is indicated by glycated haemoglobin (HbA1c). This assessment is useful for confirming short-term therapeutic efficacy during the beginning of diabetic treatment

The prominent players in the Glycated Albumin Market are Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.

Buy This Complete A Business Report With Flat US $2000 Off @

In Europe, Asahi Kasei Pharma Corporation’s new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit for glycated albumin (GA-L), acquired CE Marking in 2015. On compatible clinical chemistry analyzers, Lucica Glycated Albumin-L is used to test glycated albumin in human serum quantitatively. Lucica Glycated Albumin-L was approved in Taiwan in 2015, after receiving approval in 2013. The US Food and Drug Administration approved Diazyme Laboratories’ Enzymatic glycated serum protein (GSP, Glycated Albumin) Assay Kit in 2011. (FDA). The enzymatic glycated serum protein (GSP) assay is a two-part liquid stable reagent that may be utilised with a variety of automated clinical chemistry analyzers.  This product adds to the diagnostic value of diabetes management and screening in clinical practise. As a result, rising approval of novel glycated albumin kits launched by key industry players is likely to generate a profitable environment for global glycated albumin market growth.

The global diabetic population was around 415 million in 2015, according to the International Diabetes Federation (IDF), and is anticipated to reach 642 million by 2040. As a result, increased diabetes prevalence is predicted to boost demand for glycated albumin for diabetes diagnosis, boosting the worldwide glycated albumin assay market growth throughout the forecast period. Because of the high prevalence of diabetes in the region, North America is likely to dominate the worldwide glycated albumin market. According to data released by the American Diabetes Association in 2015, around 1.25 million children and adults in the United States had type 1 diabetes, and approximately 84.1 million persons aged 18 and up had prediabetes. Due to an increase in the number of approvals for novel glycated albumin kits in the Asia Pacific region, the glycated albumin market is likely to develop significantly. For example, Asahi Kasei Pharma Corporation’s Lucica Glycated Albumin-L got approval in Taiwan in 2015. In Indonesia and Korea, the company’s Lucica Glycated Albumin-L got approval.

Request Here For PDF Brochure

Main points in Glycated Albumin Market Report Table of Content

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.5 Global Glycated Albumin Market Size Analysis from 2021 to 2027

11.6 COVID-19 Outbreak: Glycated Albumin Industry Impact

Chapter 2 Global Glycated Albumin Competition by Types, Applications, and Top Regions and Countries

2.1 Global Glycated Albumin (Volume and Value) by Type

2.3 Global Glycated Albumin (Volume and Value) by Regions

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.2 Regional Production Market Analysis

Chapter 4 Global Glycated Albumin Sales, Consumption, Export, Import by Regions (2016-2021)

Chapter 5 North America Glycated Albumin Market Analysis

Chapter 6 East Asia Glycated Albumin Market Analysis

Chapter 7 Europe Glycated Albumin Market Analysis

Chapter 8 South Asia Glycated Albumin Market Analysis

Chapter 9 Southeast Asia Glycated Albumin Market Analysis

Chapter 10 Middle East Glycated Albumin Market Analysis

Chapter 11 Africa Glycated Albumin Market Analysis

Chapter 12 Oceania Glycated Albumin Market Analysis

Chapter 13 South America Glycated Albumin Market Analysis

Chapter 14 Company Profiles and Key Figures in Glycated Albumin Business

Chapter 15 Global Glycated Albumin Market Forecast (2021-2027)

Chapter 16 Conclusions

View Press Release For More Information

Related Reports:

Glycated Albumin Assay Market, by Product Type (Human Glycated Albumin Assay and Animal Glycated Albumin Assay), by Application (Diagnostics (Prediabetes, Type 1 Diabetes, and Type 2 Diabetes) and Research), by End User (Hospital, Diagnostic Centers, Research Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Bilirubin Colorimeter Assay Market, by Bilirubin Type (Conjugated Bilirubin (Direct Bilirubin) and Unconjugated Bilirubin (Indirect Bilirubin)), by Disease Indication (Jaundice, Hemolytic Anemia, Hyperbilirubinemia, Hepatitis, Bilirubin Encephalopathy (Kernicterus), and Others), by End User (Hospitals, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Blood Screening Market, by Technology (Nucleic acid amplification technology (NAT), ELISA, Immunoassays (IAs), Next Generation Sequencing, and Western Blotting), by Product Type (Reagents & kits and Instruments,), by End Users (Hospitals, Blood Banks, and Diagnostics laboratory), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 18-Aug-2021